Biotech

All Articles

Amgen records initial stage 3 gain for $400M dermatitis drug

.Amgen has actually discussed (PDF) the first period 3 information on its $400 million eczema medici...

Biogen, UCB record phase 3 lupus gain after failing earlier trial

.Biogen as well as UCB's depend improving in to period 3 on the back of a failed research looks to h...

Aptadir hopes brand-new RNA inhibitors can easily turn around tricky cancers

.Italian biotech Aptadir Therapeutics has actually launched along with the promise that its own pipe...

Wave surfs DMD excellence to regulators' doors, sending out stock up

.Wave Lifestyle Sciences has actually fulfilled its objective in a Duchenne muscular dystrophy (DMD)...

Sanofi picks new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, using...

Achilles drips cell treatment program, prepares for layoffs after overlooking 'industrial feasibility' goals

.Achilles Therapeutics has actually destroyed its own method. The British biotech is knocking off on...

Aligos proclaims stage 2 MASH succeed, lowering liver body fat approximately 46%

.Aligos Therapies is actually proclaiming a midstage win in metabolic-dysfunction connected steatohe...

Basilea scores $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's job cultivating brand-new antifungals has actually received a notable incre...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Possessing currently scooped up the USA civil liberties to Capricor Therapeutics' late-stage Duchen...

FDA scraps adcomm for Applied's rare condition medicine

.After dismissing the decision meeting for Applied Therapies' metabolic ailment medication govoresta...